NORTH UTTLESFORD PCN LIMITED
Company number 14528045 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
NORTH UTTLESFORD PCN LIMITED - Analysis Report
Company Number: 14528045
Analysis Date: 2025-07-20 13:49 UTC
Financial Health Assessment Report for NORTH UTTLESFORD PCN LIMITED
1. Financial Health Score: D
Explanation:
Given the very thin net asset base (£4) and current assets just balancing current liabilities, the company's financial health is fragile. The minimal equity indicates it is operating at the margin with almost no buffer for financial shocks. This earns a score of D, reflecting a "symptomatic distress" state requiring close monitoring and action.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 68,564 | Sufficient short-term resources; a positive sign. |
| Current Liabilities | 68,560 | Nearly equal to current assets, indicating very tight working capital. |
| Net Current Assets (Working Capital) | 4 | Practically zero net working capital; risky for day-to-day operations. |
| Shareholders' Funds (Equity) | 4 | Extremely low equity; company has almost no financial cushion. |
| Number of Employees | 23 | Moderate size for a micro-entity; payroll likely a significant cost. |
| Account Category | Micro | Simplified reporting, but limited financial disclosure. |
Interpretation: The company's "vital signs" show a borderline balance between short-term resources and obligations, similar to a patient whose vital signs are just stable but showing no reserve capacity. The equity base is minimal, indicating the business has very limited financial strength.
3. Diagnosis
Symptom Analysis:
The company shows symptoms of financial fragility, with current assets barely covering current liabilities, resulting in virtually no net working capital. The equity of £4 is negligible, suggesting the company is either newly formed or has yet to accumulate retained earnings or capital reserves.Underlying Health Condition:
The company is likely in an early stage, still building its financial foundation. The lack of profit and loss detail (no P&L included) means we cannot assess profitability or cash flow adequacy, which are critical for diagnosing financial stamina.Operational Context:
With 23 employees and activity in the healthcare sector (specialist and general medical practice), payroll and operational costs are likely substantial. The company must maintain balanced cash inflows from contracts or funding sources to avoid liquidity strain.Risk Factors:
The razor-thin net assets and working capital create a high risk of liquidity issues if unexpected expenses or delays in receivables occur. The company has no financial buffer to absorb shocks, resembling a patient with no immunity reserves.
4. Recommendations
Improve Capital Base:
Consider injecting additional equity capital or securing longer-term funding to build a stronger balance sheet and create a buffer.Enhance Cash Flow Management:
Monitor receivables and payables closely to ensure timely collections and payments, maintaining positive working capital.Profitability Transparency:
Provide detailed profit and loss accounts to assess operational profitability and cost control measures.Cost Control:
Review employee and operational costs to ensure sustainable expense levels relative to income.Contingency Planning:
Develop contingency plans to manage liquidity risks, such as access to overdrafts or short-term credit facilities.Regular Financial Monitoring:
Implement monthly financial reporting to detect early signs of distress and enable proactive management.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.